Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 190 (2), 358-362
- https://doi.org/10.1016/j.ajog.2003.08.041
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Economic burden of hospitalizations for preterm labor in the United StatesObstetrics & Gynecology, 2000
- The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savingsAmerican Journal of Obstetrics and Gynecology, 2000
- Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trialAmerican Journal of Obstetrics and Gynecology, 1997
- Predictors of positivity for fetal fibronectin in patients with symptoms of preterm laborAmerican Journal of Obstetrics and Gynecology, 1997
- Fetal fibronectin improves the accuracy of diagnosis of preterm laborAmerican Journal of Obstetrics and Gynecology, 1995
- Fetal Fibronectin in Cervical and Vaginal Secretions as a Predictor of Preterm DeliveryThe New England Journal of Medicine, 1991
- The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.Proceedings of the National Academy of Sciences of the United States of America, 1985